Method of treating a tumor using anti-TfR antibodies
US12037408B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2021 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Mar 11, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to humanized antibodies that specifically hind to human transferrin receptor and their use in treating cancer and inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.